Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 19, 2018
Pharmacy Choice - News - Over-the-Counter Drugs - February 19, 2018

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 18 of 18     Go To Page:

2/17/18 - Acerus Pharma's NATESTO to Be Listed for Public Reimbursement in Quebec, Building on Strong 28% Increase in Natesto's Canadian Prescriptions in Q4...
By a News Reporter-Staff News Editor at Marketing Weekly News Acerus Pharmaceuticals Corporation announced that it has received notice from Quebec's National Institute for Excellence in Health and Social Services of a positive recommendation to the Health Minister for the inclusion of NATESTO on the list of medications of the Regie de l'assura
2/16/18 - Capillus to Attend the American Academy of Dermatology's Annual Meeting in San Diego
Capillus, LLC will be exhibiting during the American Academy of Dermatology's 2018 AAD Annual Meeting, which is taking place at the San Diego Convention Center in San Diego, California from February 16th- 20th, 2018. Capillus will be located in Booth #3729 in the main aisle of the convention center's exhibition hall. Visitors to their booth will be
2/16/18 - DEC Announces 172 Pharmacies, Hospitals and Long-Term Care Facilities Participating in 2nd Round of State's Pilot Drug 'Take-Back' Program
The New York State Department of Environmental Conservation issued the following news release:. New York State Department of Environmental Conservation Commissioner Basil Seggos today announced the second group of participants in the State's $2 million Pilot Pharmaceutical Take-Back Program. "The hundreds of pharmacies and facilities participating
2/16/18 - Isodiol International Inc. Signs Definitive Agreement to Acquire 100% Of Canadian National Pharma Group Inc. [Sudan Tribune]
-Isodiol International Inc., a global CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a Definitive Agreement to acquire 100% of Canadian National Pharma Group Inc., a pharmaceutical manufacturing company. Isodiol previously announced on Dec. 6th, 2017 the agreeme
2/16/18 - KNH Unveils Antibiotics Usage Guidelines
Kenyatta National Hospital has taken the lead to develop clinical guidelines to curb potential antibiotics drug resistance. The guidelines, recently developed with support from global biopharmaceutical firm, MSD have been designed to provide a standard practice platform for all health workers at KNH responsible for the dispensing and application of
2/16/18 - New TREMFYA (guselkumab) Data Demonstrates Long-Term Skin Clearance In Patients With Moderate To Severe Plaque Psoriasis
The Janssen Pharmaceutical Companies of Johnson& Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA who achieved at least 90 percent improvement in the Psoriasis Area and Severity Index at week 28, maintained a PASI 90 response with continuous treatment through we
2/16/18 - Ortho Dermatologics Presents An Analysis Of SILIQ? (Brodalumab) Injection Phase 3 Data On Disease-Related Anxiety And Depression In Patients With Moderate-To-Severe Plaque Psoriasis
Ortho Dermatologics, a division of Valeant Pharmaceuticals North America, LLC, today announced results from an analysis of the Phase 3 clinical trial AMAGINE-1, which evaluated mental health comorbidities associated with psoriasis, such as anxiety and depression. These findings were presented for the first time at the 76 th Annual Meeting of the
2/16/18 - Pernix Therapeutics Announces Launch of Authorized Generic Version of Treximet by Company's Subsidiary, Macoven Pharmaceuticals
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, today announced the launch of an authorized generic version of Treximet in the U.S. by the Company s subsidiary, Macoven Pharmaceuticals, LLC. Treximet is a prescription medicine that contains sumatriptan and naproxen sodium and is indicated for the treatment of acute m
2/16/18 - Pharma and Healthcare Social Media Marketing to Surge at a Robust Pace in Terms of Revenue over 2025: Pharma and Healthcare Social Media Marketing- Global Industry Analysis, Size, Share, Growth and Forecast to 2025 by FMI
Valley Cottage, NY 02/16/2018 Social media platforms refer to the interaction among the people that involves creation, sharing and exchange of information and ideas in virtual networks and communities. For instance, in second week of January 2014, the U.S. Food and Drug Administration released a guidance draft for industry that needs to fulfi
2/16/18 - Researchers from Faculty of Medicine Describe Findings in Adverse Drug Reactions (Frequency and Nature of Adverse Drug Reactions Due to...
By a News Reporter-Staff News Editor at Drug Week A new study on Drugs and Therapies- Adverse Drug Reactions is now available. According to news originating from Toulouse, France, by NewsRx correspondents, research stated, "Studies that evaluate the safety of non-prescription drugs in children remain scarce. Our news journalists obtained a quote
2/15/18 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
SUMMARY: The Food and Drug Administration is publishing a list of information collections that have been approved by the Office of Management and Budget under the Paperwork Reduction Act of 1995.. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10 A-12M, 11601 Landsdown
2/15/18 - Isodiol International Inc. Signs Definitive Agreement to Acquire 100% Of Canadian National Pharma Group Inc.
Isodiol International Inc., a global CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a Definitive Agreement to acquire 100% of Canadian National Pharma Group Inc., a pharmaceutical manufacturing company. Isodiol previously announced on Dec. 6th, 2017 the agreemen
2/15/18 - Technology and Biotech Companies Poised for a Big 2018
FN Media Group Presents Microcapspeculators.com News Commentary. Advancements in technology are happening rapidly, continuously changing industries across the medical world. Included in today's commentary: Endonovo Therapeutics, Inc., Neurometrix, Inc., Zynerba Pharmaceuticals Inc., Bitcoin Investment Trust., and Helios and Matheson Analytics Inc..
2/14/18 - Sanofi bets on India with portfolio of drugs for diabetes, rare diseases [Arab Finance (Egypt)]
French drug maker Sanofi is betting on success in India and other emerging markets with its portfolio of drugs for diabetes and rare diseases, even as it recently suffered a sharp fall in its global sales. The company is ready to bring its research portfolios to India, beyond the over-the- counter products, Sanofi India managing director N Rajaram
2/13/18 - GNC and Harbin Pharmaceutical Announce $300 Million Strategic Investment and China Joint Venture
GNC Holdings, Inc. today announced it has reached an agreement regarding a strategic partnership and China joint venture agreement with Harbin Pharmaceutical Group Holding Co., Ltd, a leading pharmaceutical company in China. In addition, GNC and Hayao have agreed to form a joint venture for the manufacturing, marketing, sale and distribution of G
2/13/18 - Pivot Pharmaceuticals Provides Corporate Update [T-break Tech (Middle East)]
-Pivot Pharmaceuticals Inc., a biopharmaceutical company engaged in the development and commercialization of cannabinoid-based therapeutics using innovative drug formulation and delivery platform technologies, is pleased to provide its shareholders with the following Corporate Update. Acquisition of ERS Holdings, LLC and...
2/12/18 - ACETO Subsidiary Rising Pharmaceuticals Launches Atenolol Tablets 25mg 50mg and 100mg
PORT WASHINGTON- ACETO Corporation, an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, has launched Atenolol Tablets, 25 mg, 50 mg and 100 mg, a
2/12/18 - TEVA PHARMACEUTICAL INDUSTRIES LTD - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
We operate worldwide, with headquarters in Israel and a significant presence in the United States, Europe and many other markets around the world. Teva was incorporated in Israel on February 13, 1944, and is the successor to a number of Israeli corporations, the oldest of which was established in 1901.. Under this new structure, our business will b
Articles(s): 1 - 18 of 18     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415